Testing effectiveness (Phase 2)Looking for participantsNCT06601127
What this trial is testing
Study of Tiprogrel in the Treatment of High-risk Patients with Acute Ischemic Cerebrovascular Events (THRIVE).
Who this might be right for
Ischemic Stroke
Tianjin Institute of Pharmaceutical Research Co., Ltd 600